OQS
ABOS icon

Occudo Quantitative Strategies’s Acumen Pharmaceuticals ABOS Stock Holding History

Occudo Quantitative Strategies’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,929
Closed -$65K – 702
2023
Q4 		$65K Buy
+16,929
New +$50.3K 0.01% 731

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Occudo Quantitative Strategies's ABOS Position: Q1 2024 in Review

Occudo Quantitative Strategies sold out of Acumen Pharmaceuticals (ABOS) in Q1 2024, closing a stake of 16,929 shares — an estimated $65K sold.

Occudo Quantitative Strategies first reported a position in ABOS in Q4 2023 and held it in 1 quarter. The position peaked at $65K in Q4 2023. 80 funds tracked by Wall St. Rank hold ABOS as of Q1 2024.

  • Occudo Quantitative Strategies reported no remaining Acumen Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 16,929 Acumen Pharmaceuticals shares in Q1 2024, an estimated $65K.
  • Occudo Quantitative Strategies first reported a position in Acumen Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Acumen Pharmaceuticals position peaked at $65K in Q4 2023.
  • 80 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2024, filed 15 May 2024.